Cyagen
Cyagen
  • Видео 165
  • Просмотров 1 048 685
Q&A Episode 6: How do you view AI’s role in life sciences and its future impact on genome editing?
🌟 Welcome back to our interview series! 🌟
In this episode, Marvin from Cyagen joins us to discuss the transformative role of AI in life science research and its integration with genome editing technologies. Marvin explains how AI technology is revolutionizing fields like genomics and drug discovery by enhancing data analysis, target identification, and the optimization of gene editing tools such as CRISPR-Cas9. He delves into how AI-driven platforms facilitate rapid advancements in precision medicine and personalized therapeutics, ultimately accelerating the development of novel treatments and interventions. Join us as Marvin shares his insights on the potential transformations anticipated...
Просмотров: 10

Видео

How Can We Enhance Immunotherapy Research with Humanized Mice?
Просмотров 677 часов назад
📽️ Humanized Immune System Mouse Models for Advancing Immunotherapy Welcome to our latest video! Reza from Cyagen introduces our cutting-edge humanized immune system mouse models: NKG-hIL15 and huHSC-NKG-hIL15. These models are designed to mimic human immune responses, overcoming the limitations of traditional HIS mice in NK cell reconstitution. Key Highlights: ✅IL-15’s Role: Enhances NK cell a...
Q&A Episode 5: Do you anticipate similar initiatives from competitors soon for HUGO-GT?
Просмотров 1116 часов назад
🌟 Welcome back to our interview series! 🌟 Join us as we continue our discussion on groundbreaking advancements in preclinical drug development with Marvin from Cyagen. In this episode, Marvin sheds light on Cyagen's HUGO-GT whole-genome humanized mouse project and its unique advantages over traditional models, including comprehensive humanization coverage and compatibility with diverse therapeu...
Q&A Episode 3: Could you provide insights into Cyagen's newly launched "HUGO-GT"?
Просмотров 2421 час назад
In this interview, Marvin introduces the revolutionary HUGO-GT™ Program. Unlike traditional models, HUGO-GT™ replaces mouse genes with human counterparts, retaining the complete human genome sequence. This enhances gene expression accuracy and allows precise disease-specific mutations, offering a more relevant platform for gene therapy research. The global HUGO-GT™ program aims to expand gene t...
Webinar: Accelerating Antibody Drug Discovery with Biointron's AbDrop® and Cyagen's HUGO-Ab®
Просмотров 3821 час назад
Fully human antibodies are revolutionizing cancer and autoimmune disease therapies with superior affinity and specificity. In this webinar, hosted by Cyagen and Biointron, Dr. Shun Zhou explores the groundbreaking potential of HUGO-Ab™ mouse models. These genome-edited mice feature fully human VH and VL genes, enabling high-throughput, efficient antibody discovery. Learn about the innovative te...
Q&A Episode 2: What advantages do humanized mouse models offer over traditional mouse models?
Просмотров 13День назад
Welcome back to our interview series! Today, we're exploring humanized mouse models with Cyagen's expert, Marvin. Marvin explains: The advantages of humanized mouse models over traditional ones, including more clinically relevant insights into human diseases. How Cyagen's HUGO-Ab model advances therapeutic antibody discovery with high-affinity antibody production. The role of these models in ac...
Q&A Episode 1: Why are mice a good model for studying human genes?
Просмотров 4021 день назад
Welcome to our Q&A series! 🌟In this video, Marvin will answer the question: Why are mice a good model for studying human genes? Join us as we dive into the biotech world and explore the fascinating connections between mice and human genetics.
Advanced Research on MASH Using Cyagen's Composite Mouse Models
Просмотров 7328 дней назад
Join Reza from Cyagen as we explore groundbreaking research into metabolic dysfunction-associated steatohepatitis (MASH). Discover how Cyagen's composite mouse models are advancing preclinical drug development for this severe liver disease. Learn how Cyagen's models bridge the gap between lab research and clinical applications in liver disease treatment. 🔔 Subscribe for more insights from Cyage...
Unlocking the Mysteries of Fabry Disease with Gla-KO Mice
Просмотров 16128 дней назад
Unlocking the Mysteries of Fabry Disease with Gla-KO Mice Join Reza from Cyagen as we explore Fabry Disease (FD), a complex genetic disorder with significant challenges in diagnosis and treatment. This video dives into the genetic causes, current treatments, and the groundbreaking role of Cyagen’s Gla-KO mice in advancing FD research. Topics Covered: ✅Understanding Fabry Disease: Genetic mutati...
How Can Humanized Mice Transform Transthyretin Amyloidosis Treatment?
Просмотров 31Месяц назад
Join Reza from Cyagen as he explores Transthyretin Amyloidosis (ATTR), its development, and current treatments. Discover how Cyagen's advanced humanized mouse models, like B6-hTTR and H11-Alb-hTTR*V50M, are revolutionizing research and paving the way for groundbreaking therapies. Learn about innovative strategies targeting the TTR gene and the significant role these models play in advancing per...
Debut of the HUGO-GT™ Humanized Model at the Global Rare Disease Research Symposium
Просмотров 71Месяц назад
Discover the groundbreaking advancements in genetic research with the HUGO-GT™ Next-Generation Humanized Models, unveiled at the Global Rare Disease Research Forum! - The "Universal Template" for Studying Gene Mutations - The "Ideal Model" for Studying Genetic Diseases - The "Technological Revolution" that Accelerates Gene Therapy Join us as Lance Han, Founder CEO of Cyagen Biosciences and Dire...
The HUGO-GTᵀᴹ B6-hIGHMBP2 Mouse Model Revolutionizing Neuromuscular Disease Research
Просмотров 572 месяца назад
Journey into neuromuscular disease research with Cyagen! Discover our groundbreaking HUGO-GTᵀᴹ B6-hIGHMBP2 mouse model, engineered to mirror genetic complexities underlying conditions like CMT2S and SMARD1. Uncover insights, precision therapies, and hope for patients worldwide. Join us today to redefine what's possible. Artificial intelligence services provided by Cyrinn www.cyrinn.cn/ You can ...
Advancing Parkinson's Disease Research with B6-hSNCA Mouse Model
Просмотров 482 месяца назад
Explore the B6-hSNCA mouse model with Reza from Cyagen, designed for Parkinson's Disease Dementia research. This model sheds light on PD and Dementia with Lewy Bodies, supporting the quest for new treatments. Learn how it's shaping the future of Parkinson's therapy, targeting alpha-synuclein pathology. Discover more about this crucial model and its role in PD research. Artificial intelligence s...
Unveiling the Potential of F9 KO Mice: Exploring Hemophilia B Research
Просмотров 412 месяца назад
Unveiling the Potential of F9 KO Mice: Exploring Hemophilia B Research
Advancing Psoriasis Research: A Deep Dive into Cyagen's B6-hIL-17A Mouse Model
Просмотров 342 месяца назад
Advancing Psoriasis Research: A Deep Dive into Cyagen's B6-hIL-17A Mouse Model
World Day for Laboratory Animals 24 April | Arrive 2.0 Guideline
Просмотров 573 месяца назад
World Day for Laboratory Animals 24 April | Arrive 2.0 Guideline
Advancing SCA3 Research: Introducing the B6-hATXN3 Mouse Model by Cyagen
Просмотров 1083 месяца назад
Advancing SCA3 Research: Introducing the B6-hATXN3 Mouse Model by Cyagen
Introducing Our Newest Research Model: The KS Mouse for Lung Cancer Studies
Просмотров 703 месяца назад
Introducing Our Newest Research Model: The KS Mouse for Lung Cancer Studies
Unlocking RP Solutions: The Power of Cyagen's HUGO-GT and B6J-hRHO Mice
Просмотров 473 месяца назад
Unlocking RP Solutions: The Power of Cyagen's HUGO-GT and B6J-hRHO Mice
Unveiling the Future of Gene Therapy: Cyagen's Breakthrough in SCA3 Treatment
Просмотров 1714 месяца назад
Unveiling the Future of Gene Therapy: Cyagen's Breakthrough in SCA3 Treatment
Unveiling the Path to Gene Therapy for Rett Syndrome | Cyagen
Просмотров 1234 месяца назад
Unveiling the Path to Gene Therapy for Rett Syndrome | Cyagen
How to Thaw a Gradually Frozen Life? - Amyotrophic Lateral Sclerosis (ALS)
Просмотров 746 месяцев назад
How to Thaw a Gradually Frozen Life? - Amyotrophic Lateral Sclerosis (ALS)
助罕见在行动|如何应对眼科“绝症“--视网膜色素变性(RP)
Просмотров 1699 месяцев назад
助罕见在行动|如何应对眼科“绝症“ 视网膜色素变性(RP)
云参观赛业生物眼科基因治疗CRO平台-从困境到方案,助力眼科新药临床开发!
Просмотров 759 месяцев назад
云参观赛业生物眼科基因治疗CRO平台-从困境到方案,助力眼科新药临床开发!
机理不明,药物难寻?一节课为你解析阿尔茨海默症(AD)的药物开发进展和研究痛点!
Просмотров 1989 месяцев назад
机理不明,药物难寻?一节课为你解析阿尔茨海默症(AD)的药物开发进展和研究痛点!
一小时掌握构建条件性基因敲除鼠的必要工具--Cre工具鼠!
Просмотров 27511 месяцев назад
一小时掌握构建条件性基因敲除鼠的必要工具 Cre工具鼠!
10 Deadly Sins|Infertility--TUBB8&USP26 Genes(with CC)
Просмотров 4211 месяцев назад
10 Deadly Sins|Infertility TUBB8&USP26 Genes(with CC)
10 Deadly Sins|Riley-Day Syndrome
Просмотров 42511 месяцев назад
10 Deadly Sins|Riley-Day Syndrome
10 Deadly Sins|Spinocerebellar Ataxia(with CC)
Просмотров 15211 месяцев назад
10 Deadly Sins|Spinocerebellar Ataxia(with CC)
10 Deadly Sins|Wilson's Disease
Просмотров 31Год назад
10 Deadly Sins|Wilson's Disease

Комментарии

  • @evabogatec398
    @evabogatec398 7 дней назад

    More funding for autism. Gene therapy

  • @MunsKi
    @MunsKi 11 дней назад

    it sounds like a complicated selective breeding...

  • @MunsKi
    @MunsKi 11 дней назад

    how is proteins like primase and polymerase are created/?

  • @leads123
    @leads123 15 дней назад

    我可免费治疗。

  • @Tûrkok-Y
    @Tûrkok-Y 17 дней назад

    Tic 1000K😊

  • @Tûrkok-Y
    @Tûrkok-Y 17 дней назад

    Yo🥀🔥

  • @_ItzMilo_957
    @_ItzMilo_957 Месяц назад

    My brother has Dmd, and he’s 10 but super short :( it’s sad so I hope they cure DMD

  • @RIO-OREO-SUPER-STARS
    @RIO-OREO-SUPER-STARS Месяц назад

    American pushing has to get cancer diabetic all Disease 🦠 with food

  • @AshleyHuang-rh1se
    @AshleyHuang-rh1se Месяц назад

    Insightful presentation!👍

  • @cherylchen8297
    @cherylchen8297 Месяц назад

    👍Great talk!!

  • @johnkalina8895
    @johnkalina8895 2 месяца назад

    Solid video my guy. Brief, simply explained, but still detailed. Exactly what I was looking for

  • @RiverSprite30
    @RiverSprite30 2 месяца назад

    90 Day fiance sent me here. That weirdo, Kyle, has it.

  • @lilyzhang5540
    @lilyzhang5540 3 месяца назад

    💪💪💪🦾🦾🦾🤝🙏🙏🙏实在就不活了,可以冷冻住,可以在以后复活🤞

  • @Galen02
    @Galen02 3 месяца назад

    I got retinitis pigmentosa and it really makes my life SO hard, hoping a cure is discovered soon.

  • @HoodWill1
    @HoodWill1 3 месяца назад

    If the world had more people like Dr Obulor it will be a better place to be, I sincerely appreciate you doctor for all you have done in helping me get rid of diabetes completely. His on RUclips💛.

  • @HoodWill1
    @HoodWill1 3 месяца назад

    If the world had more people like Dr Obulor it will be a better place to be, I sincerely appreciate you doctor for all you have done in helping me get rid of diabetes completely. His on RUclips💛.

  • @lowtengyuh1995
    @lowtengyuh1995 3 месяца назад

    ruclips.net/video/U-LK8b2zxOc/видео.htmlsi=cvjHNk6xXXRcA30P

  • @Cyagen
    @Cyagen 4 месяца назад

    "Rett Syndrome, RTT" Due to inaccuracies in the automatically matched subtitles, please ensure careful screening for accuracy. Thank you.☺

  • @jaym9846
    @jaym9846 4 месяца назад

    I take 2 pills of FGF21 everyday.

  • @anuragsingh9853
    @anuragsingh9853 4 месяца назад

    Best explanation every under a minute

  • @meizhang9828
    @meizhang9828 5 месяцев назад

    喜欢你的标题,机理不明,药物难寻,机理是不是该在(分母)找不明,(分子)是因(分母)的变化而变化,这是物理法则。 45:24

  • @meizhang9828
    @meizhang9828 5 месяцев назад

    喜欢你的标题,机理不明,药物难寻,机理是不是该在(分母)是找不明?(分子)的变化是(分母)的变化而变化。这是物理法则 纯粹是个人想法不对您纠正。

  • @soniakhan9472
    @soniakhan9472 6 месяцев назад

    Will the resultant mice be heterozygous for the knocked-in gene?

  • @bassomalbarasy2214
    @bassomalbarasy2214 6 месяцев назад

    Thank you 🥺♥️♥️

  • @dannyvdmoo
    @dannyvdmoo 6 месяцев назад

    china must stop this experimental covid on mice

  • @user-nw7ln2lx1m
    @user-nw7ln2lx1m 7 месяцев назад

    下次你做演讲的时候,演讲稿要大声读20遍。 在做视频

  • @pcdgovernance5494
    @pcdgovernance5494 7 месяцев назад

    Everything is posible in stem cell therapy BUT pharms dont want to do this

  • @brothernet
    @brothernet 7 месяцев назад

    10:30 讲到的细胞DNA貌似基本概念错误

  • @brothernet
    @brothernet 7 месяцев назад

    口齿不清。听不懂。

  • @lissakaye610
    @lissakaye610 8 месяцев назад

    I have only worked with an autistic mouse model once and they were nuts. Absolutely adorable, but very difficult to handle. Very interesting video, thanks.

  • @richashrivastava3981
    @richashrivastava3981 8 месяцев назад

    If we do PCR of all ESC, how are we left with cells to be implanted in the new mice blastocyst?

    • @Cyagen
      @Cyagen 8 месяцев назад

      Typically, one or more subcultures of cells can be made for analysis and selection of the correctly modified cells.

    • @richashrivastava3981
      @richashrivastava3981 8 месяцев назад

      Thanks@@Cyagen

  • @hayleydowling3012
    @hayleydowling3012 8 месяцев назад

    Nice!

  • @zinc7874
    @zinc7874 8 месяцев назад

    thank you

  • @janicezhang54
    @janicezhang54 9 месяцев назад

    太佩服蔡磊了,他是一个伟大的人,希望他成功!

  • @rhyslormand703
    @rhyslormand703 10 месяцев назад

    Explained 100x better than my professor! Awesome video.

    • @Cyagen
      @Cyagen 10 месяцев назад

      Thanks, we are happy it helped better explain knockout mice for you!☺

  • @powersoftruth
    @powersoftruth 10 месяцев назад

    本人有治疗缓解渐冻症的方法。

  • @vincentwiese8414
    @vincentwiese8414 10 месяцев назад

    THEY WILL NEVER CURE IT IN HUMANS

    • @rocco...
      @rocco... 4 месяца назад

      "They" are the $50 billion a year association who are raking in all that money!

    • @mamen6486
      @mamen6486 21 день назад

      But the project had promising results, as he said its a potential cure, not a suggestion

  • @madymeldrum903
    @madymeldrum903 10 месяцев назад

    Can you explain why/how CRISPR/Cas9 would be used in conjunction with Cre/LoxP recombination? It seems like both can create knockout mice, so is it not redundant then to use them together?

    • @Cyagen
      @Cyagen 10 месяцев назад

      CRISPR/Cas9 and Cre/LoxP recombination are two distinct genetic engineering tools that serve different purposes in the generation of knockout mice, and they can be used in conjunction for specific applications. While both techniques can be used to create knockout mice, they are not redundant, and their combined use can provide certain advantages. 1. CRISPR/Cas9 for Gene Targeting: Introduction of Mutations: CRISPR/Cas9 technology is commonly used to introduce specific mutations in a target gene. It involves designing a guide RNA (gRNA) that guides the Cas9 enzyme to a specific DNA sequence, where it induces double-strand breaks (DSBs). These DSBs can lead to insertions or deletions (indels) during the repair process, resulting in gene disruption or knockout. 2. Cre/LoxP Recombination: Conditional Knockouts: Cre/LoxP recombination is a tool used to achieve conditional gene knockout. It involves the use of two key elements: Cre recombinase enzyme and LoxP recognition sites. LoxP sites are inserted flanking a gene of interest, and Cre recombinase catalyzes recombination between these sites. This process can lead to the excision of the floxed gene, effectively knocking it out in a tissue-specific or inducible manner. Using both CRISPR/Cas9 and Cre/LoxP recombination together can offer the following advantages: 1. Precise Targeting: CRISPR/Cas9 allows for precise modification of a specific gene at its endogenous locus, ensuring that the mutation is introduced exactly where it's needed. 2. Flexibility: Cre/LoxP recombination enables conditional knockout strategies, allowing researchers to control when and where a gene is disrupted. This is particularly useful for studying genes with essential functions at different stages of development or in specific tissues. 3. Tissue-Specific Knockouts: By combining CRISPR/Cas9 and Cre/LoxP, researchers can create knockout mice with tissue-specific gene disruption. CRISPR/Cas9 is used to introduce LoxP sites or other modifications to the target gene, and Cre recombinase is subsequently expressed under the control of a tissue-specific promoter. 4. Temporal Control: Cre/LoxP allows for temporal control of gene knockout, whereas CRISPR/Cas9 disrupts the gene permanently. This temporal control can be critical for studying genes with complex functions that change over time. In summary, while both CRISPR/Cas9 and Cre/LoxP recombination can be used to create knockout mice, they serve complementary roles. CRISPR/Cas9 is primarily used for precise gene editing, while Cre/LoxP recombination offers conditional and tissue-specific knockout capabilities. Combining these techniques allows researchers to achieve more sophisticated and flexible control over gene knockout experiments, making it a valuable strategy in mouse genetics research.

  • @sumanlimbusongpangbay
    @sumanlimbusongpangbay 10 месяцев назад

    Dear sir, my daughter is suffering from LCA5 eye disfunction since when she was about 1 month and my baby is now about 15 months so please advise for the treatment. 🙏

  • @davidjoines8497
    @davidjoines8497 11 месяцев назад

    I would think that to take a daily vitamin A supplement it is great idea and even if it does not impact the progression of R.P. it is also very good for one’s overall health.

  • @asaurdreams1850
    @asaurdreams1850 11 месяцев назад

    bro kept saying all timers disease

  • @sybylviles7114
    @sybylviles7114 Год назад

    'promosm' ✔️

  • @Cyagen
    @Cyagen Год назад

    More information about our knockout mice could be found at: www.cyagen.com/us/en/service/crispr-based-genome-editing-knockout-mice.html

  • @shri_harshabhat4069
    @shri_harshabhat4069 Год назад

    Pls send notes of this

    • @Cyagen
      @Cyagen Год назад

      Thanks for your interest in our knockout mice. More information could be found at: www.cyagen.com/us/en/service/crispr-based-genome-editing-knockout-mice.html

  • @Cyagen
    @Cyagen Год назад

    Register for our webinar to learn about the rapid advancements in preclinical ophthalmic gene therapy research! www.cyagen.com/us/en/community/promotions/gene-therapy-ophthalmic-diseases.html

  • @Cyagen
    @Cyagen Год назад

    Register for our webinar to learn about the rapid advancements in preclinical ophthalmic gene therapy research! www.cyagen.com/us/en/community/promotions/gene-therapy-ophthalmic-diseases.html